vancomycin has been researched along with Erysipelas in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bolac, C; Brassat, S; Camus, M; Cante, V; Guillet, G; Paquier-Valette, C | 1 |
| Bernardo, P; Biermann, EJ; Donfrid, B; Eisenstein, BI; Link, AS; Martone, WJ; Pertel, PE | 1 |
| Georgala, S; Krasagakis, K; Maniatakis, P; Samonis, G; Tosca, A | 1 |
1 trial(s) available for vancomycin and Erysipelas
| Article | Year |
|---|---|
The efficacy and safety of daptomycin vs. vancomycin for the treatment of cellulitis and erysipelas.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Cellulitis; Daptomycin; Erysipelas; Female; Humans; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vancomycin; Young Adult | 2009 |
2 other study(ies) available for vancomycin and Erysipelas
| Article | Year |
|---|---|
[Endogenous endophthalmitis as a complication in erysipelas].
Topics: Antifungal Agents; Bacteremia; Ceftazidime; Diabetes Mellitus, Type 2; Disease Susceptibility; Drug Therapy, Combination; Endophthalmitis; Erysipelas; Eye Infections, Bacterial; Humans; Imipenem; Intertrigo; Leg; Levofloxacin; Male; Middle Aged; Obesity; Streptococcus agalactiae; Uveitis, Anterior; Vancomycin | 2013 |
Bullous erysipelas: clinical presentation, staphylococcal involvement and methicillin resistance.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefuroxime; Cloxacillin; Drug Therapy, Combination; Erysipelas; Female; Humans; Male; Methicillin; Methicillin Resistance; Middle Aged; Netilmicin; Penicillins; Skin; Staphylococcus; Treatment Outcome; Vancomycin | 2006 |